Assessment of private variants in PRKN, PARK7 and PINK1 in Parkinson’s disease
Jing Hu, Cheryl H. Waters, Dan Spiegelman, View ORCID ProfileEdward A. Fon, View ORCID ProfileEric Yu, Farnaz Asayesh, Lynne Krohn, Prabhjyot Saini, View ORCID ProfileRoy N. Alcalay, Sharon Hassin-Baer, Ziv Gan-Or, View ORCID ProfileDimitri Krainc, BaoRong Zhang, Bernabe I. Bustos, Steven J. Lubbe, the International Parkinson’s Disease Genomics Consortium (IPDGC)
doi: https://doi.org/10.1101/2022.02.18.22269402
Jing Hu
1Department of Neurology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China
2Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Cheryl H. Waters
3Department of Neurology, Columbia University Irving Medical Center
Dan Spiegelman
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
Edward A. Fon
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
5The Department of Neurology & Neurosurgery, McGill University, Montreal, Quebec, Canada
Eric Yu
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
6The Department of Human Genetics, McGill University, Montreal, Quebec, Canada
Farnaz Asayesh
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
5The Department of Neurology & Neurosurgery, McGill University, Montreal, Quebec, Canada
Lynne Krohn
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
6The Department of Human Genetics, McGill University, Montreal, Quebec, Canada
Prabhjyot Saini
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
6The Department of Human Genetics, McGill University, Montreal, Quebec, Canada
Roy N. Alcalay
3Department of Neurology, Columbia University Irving Medical Center
7Center of Movement Disorders, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Sharon Hassin-Baer
8The Movement Disorders Institute, Department of Neurology, Chaim Sheba Medical Center, Tel-Hashomer, Israel
9The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Ziv Gan-Or
4The Neuro (Montreal Neurological Institute-Hospital), Montreal, Quebec, Canada
5The Department of Neurology & Neurosurgery, McGill University, Montreal, Quebec, Canada
6The Department of Human Genetics, McGill University, Montreal, Quebec, Canada
Dimitri Krainc
2Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
BaoRong Zhang
1Department of Neurology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China
Bernabe I. Bustos
2Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
Steven J. Lubbe
2Ken and Ruth Davee Department of Neurology and Simpson Querrey Center for Neurogenetics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA

Data Availability
All genetic data used in this study is available (upon application) from the following sites: (i) Accelerating Medicines Partnership: Parkinson's Disease (https://amp-pd.org). (ii) International Parkinson's Disease Genomics Consortium (https://pdgenetics.org/resources). (iii) Parkinson's Disease Variant Browser (https://pdgenetics.shinyapps.io/VariantBrowser). (iv) Dataset using targeted next-generation sequencing with Molecular inversion probes (https://cbigr-open.loris.ca/)
Posted March 04, 2022.
Assessment of private variants in PRKN, PARK7 and PINK1 in Parkinson’s disease
Jing Hu, Cheryl H. Waters, Dan Spiegelman, Edward A. Fon, Eric Yu, Farnaz Asayesh, Lynne Krohn, Prabhjyot Saini, Roy N. Alcalay, Sharon Hassin-Baer, Ziv Gan-Or, Dimitri Krainc, BaoRong Zhang, Bernabe I. Bustos, Steven J. Lubbe, the International Parkinson’s Disease Genomics Consortium (IPDGC)
medRxiv 2022.02.18.22269402; doi: https://doi.org/10.1101/2022.02.18.22269402
Assessment of private variants in PRKN, PARK7 and PINK1 in Parkinson’s disease
Jing Hu, Cheryl H. Waters, Dan Spiegelman, Edward A. Fon, Eric Yu, Farnaz Asayesh, Lynne Krohn, Prabhjyot Saini, Roy N. Alcalay, Sharon Hassin-Baer, Ziv Gan-Or, Dimitri Krainc, BaoRong Zhang, Bernabe I. Bustos, Steven J. Lubbe, the International Parkinson’s Disease Genomics Consortium (IPDGC)
medRxiv 2022.02.18.22269402; doi: https://doi.org/10.1101/2022.02.18.22269402
Subject Area
Subject Areas
- Addiction Medicine (576)
- Allergy and Immunology (868)
- Anesthesia (306)
- Cardiovascular Medicine (4482)
- Dermatology (385)
- Emergency Medicine (615)
- Epidemiology (15277)
- Forensic Medicine (31)
- Gastroenterology (1133)
- Genetic and Genomic Medicine (6644)
- Geriatric Medicine (671)
- Health Economics (1006)
- Health Informatics (4605)
- Health Policy (1378)
- Hematology (544)
- HIV/AIDS (1276)
- Medical Education (626)
- Medical Ethics (147)
- Nephrology (674)
- Neurology (6695)
- Nursing (346)
- Nutrition (1006)
- Obstetrics and Gynecology (1153)
- Oncology (3369)
- Ophthalmology (988)
- Orthopedics (370)
- Otolaryngology (421)
- Pain Medicine (437)
- Palliative Medicine (131)
- Pathology (669)
- Pediatrics (1704)
- Primary Care Research (717)
- Public and Global Health (9285)
- Radiology and Imaging (2223)
- Respiratory Medicine (1201)
- Rheumatology (598)
- Sports Medicine (535)
- Surgery (722)
- Toxicology (100)
- Transplantation (290)
- Urology (267)




